Clinical Trial Update: Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating adipose-derived mesenchymal stem cells for sexual hormone deficiency has completed, with reported outcomes from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Adipose-derived mesenchymal stem cells

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Hormone Deficiency | Phase 1, Phase 2 | Status: COMPLETED